Effectively Handling Challenges in Clinical Trial Disclosure

Download Whitepaper

By clicking ‘Submit’ button, you are agreeing to opt-in to communications from ArisGlobal and use of the above information for ArisGlobal products, news & updates.

Note: You can unsubscribe to email communication from ArisGlobal any time.

The industry has made significant progress when it comes to the transparent disclosure of clinical study information to researchers, investigators and stakeholders. Managing dynamic clinical trial data and working with evolving health authority requirements on a global basis can be complex, and the sheer quantity of trials being conducted today only increases that complexity. It’s imperative that companies keep up-to-speed with new clinical trial transparency regulations and find ways to best handle regulations and transparency.

This white paper will examine some of the challenges associated with the different aspects of clinical trial disclosure and provide possible ways to achieve greater transparency.

Download this paper to learn about:

  • The history of clinical trial transparency, progress made so far and the challenges that remain
  • How to regain public trust by disclosing clinical trial information and trial results
  • The different aspects of clinical trial disclosure involve and the challenges they face, including data sharing, junk science, EudraCT results disclosure, publication of the clinical study report and information redaction, lay summary, consistency and other future challenges.